AKT1 and lung adenocarcinoma: NEDD4L inhibited lung adenocarcinoma cell progression in vitro and in vivo via inducing the ubiquitination‐mediated Ubiquitin‐conjugating enzyme E2T (UBE2T) degradation, which repressed PI3K‐Akt signalling.38